|
WO2019058382A1
|
|
An automated multi-use injecting system for administration of injectable medicaments
|
|
WO2018078643A1
|
|
Monoclonal antibodies neutralizing the tetanus toxin
|
|
BR112019002267A2
|
|
implant injection system / safety housing-based medicine
|
|
AU2014200308A1
|
|
Anti-RhD monoclonal antibodies
|
|
AU2009336567A1
|
|
Anti-RhD monoclonal antibodies
|
|
CN102105134A
|
|
Stable injectable oil-in-water docetaxel nanoemulsion
|
|
WO2008023384A1
|
|
Propofol emulsion compositions for intravenous administration
|
|
EP1928412A2
|
|
Aqueous anaesthetic compositions comprising propofol
|
|
KR20080043793A
|
|
Intravenous propofol emulsion compositions having preservative efficacy
|
|
AU2005283726A1
|
|
Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
|
|
CN1756533A
|
|
Non-pegylated long-circulating liposomes
|
|
KR20050089153A
|
|
Ifosfamide compositions for parenteral administration and a process for their preparation
|
|
US2004186074A1
|
|
Aqueous ifosfamide compositions for parenteral administration and a process for their preparations
|
|
WO2004022699A2
|
|
Liquid stable composition of oxazaphosphorine with mesna
|
|
WO0245709A1
|
|
Clear propofol compositions
|
|
WO0197778A2
|
|
Amphotericin b structured emulsion
|
|
NZ528281A
|
|
Amphotericin B aqueous composition and a process for preparing the same
|
|
AP200202674A0
|
|
Clear aqueous anaesthetic compositions
|
|
CZ20024044A3
|
|
Clear, aqueous composition containing anesthetic
|
|
IL153387D0
|
|
Clear aqueous anaesthetic composition
|
